| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/03/2005 | EP1559710A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV, process for their preparation and their use |
| 08/03/2005 | EP1559438A1 Hemostatic compositions and devices |
| 08/03/2005 | EP1559424A2 The use of inhibitors of the renin-angiotensin system |
| 08/03/2005 | EP1559418A1 Compositions for treating pain of the mucous membrane |
| 08/03/2005 | EP1559328A1 Fungal feeds for aquaculture and agriculture |
| 08/03/2005 | EP1559327A1 Bacterial feeds for aquaculture and agriculture |
| 08/03/2005 | EP1559321A1 Mixed compositions for controlling parasitic insects |
| 08/03/2005 | EP1559317A1 Nonbacterial prostatitis model animal |
| 08/03/2005 | EP1558586A2 Inhibitors of akt activity |
| 08/03/2005 | EP1558289A1 Pharmaceutical composition comprising a cdk inhibitor and gemcitabine |
| 08/03/2005 | EP1558288A1 Gastric acid secretion inhibiting composition |
| 08/03/2005 | EP1558273A2 Treatment and prevention of pulmonary conditions |
| 08/03/2005 | EP1558256A1 Pyrroloquinoline quinone for treatment of cardiac injury and methods of use thereof |
| 08/03/2005 | EP1558249A1 Use of tacrolimus (fk506) derivatives combined with beta2-agonists for the treatment of asthma |
| 08/03/2005 | EP1558245A2 Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases |
| 08/03/2005 | EP1558244A2 Novel nutraceutical compositions comprising epigallocatechin gallate |
| 08/03/2005 | EP1558238A2 Beta-hydroxyphenylaldylamines and their use for treating glaucoma |
| 08/03/2005 | EP1558228A1 Topical administration of basic antifungal compositions to treat fungal infections of the nails |
| 08/03/2005 | EP1558220A1 Oral compositions for treatment of diseases |
| 08/03/2005 | EP1558210A2 Cartilage enhancing food supplements with sucralose and methods of preparing the same |
| 08/03/2005 | EP1558199A2 Therapeutic combination of carnitine and antioxidant polyphenols |
| 08/03/2005 | EP1558084A2 Treatment for hemorrhagic shock |
| 08/03/2005 | EP1558081A2 Method of treating functional bowel disorders |
| 08/03/2005 | EP1558078A2 Acidified chlorite compositions containing nitrogenous stabilizers and systems and methods related thereto |
| 08/03/2005 | EP1280527B1 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione |
| 08/03/2005 | EP1227806B1 Pharmaceutical formulation containing tolterodine and its use |
| 08/03/2005 | EP1207861B1 Treatment of fungal infections utilizing a fungal growth medium |
| 08/03/2005 | EP1140173B1 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/03/2005 | EP1140106B1 Treatment of diseases involving cyst formation |
| 08/03/2005 | EP1131344B1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof |
| 08/03/2005 | EP0998288B2 Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
| 08/03/2005 | EP0815231B1 Use of neuronal apoptosis inhibitor protein (naip) |
| 08/03/2005 | CN1650169A Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/03/2005 | CN1650033A Genomic screen for epigenetically silenced genes associated with cancer |
| 08/03/2005 | CN1650024A Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |
| 08/03/2005 | CN1650012A Antigens encoded by alternative reading frame from pathogenic viruses |
| 08/03/2005 | CN1650001A Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinop |
| 08/03/2005 | CN1649870A 7-aryl-3, 9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 08/03/2005 | CN1649869A Azaindoles as inhibitors of c-Jun N-terminal kinases |
| 08/03/2005 | CN1649627A Methods and conpositions for treating, preventing or delaying onset of a neoplasm |
| 08/03/2005 | CN1649624A Use of TNF alpha antibodies and another drug |
| 08/03/2005 | CN1649618A Methods |
| 08/03/2005 | CN1649616A Methods and compositions for the treatment of ischemia |
| 08/03/2005 | CN1649614A Active agent delivery systems and methods for protecting and administering active agents |
| 08/03/2005 | CN1649605A Use of topical compositions for the control of microbial diseases of the nail |
| 08/03/2005 | CN1649604A Separate type medical material |
| 08/03/2005 | CN1649602A Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 08/03/2005 | CN1649597A Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same |
| 08/03/2005 | CN1649591A Tricyclic compounds useful as HIV reverse transcriptase inhibitors |
| 08/03/2005 | CN1649588A New pharmaceutical compositions based on anticholinergics and PED-IV inhibitors |
| 08/03/2005 | CN1649585A Epothilone derivative for the treatment of hepatoma and other cancer diseases |
| 08/03/2005 | CN1649583A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 08/03/2005 | CN1649580A Pharmaceutical composition comprising a lipase inhibitor and glucomannan |
| 08/03/2005 | CN1649577A Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 08/03/2005 | CN1649576A Methods and compositions for treatment of cancer pain |
| 08/03/2005 | CN1649569A Controlled release dosage forms |
| 08/03/2005 | CN1649513A Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 08/03/2005 | CN1647827A Method and device for the treatment of obesity |
| 08/03/2005 | CN1213059C Rapid dehydration of proteins |
| 08/03/2005 | CN1213058C FAP-activated anti-tumor compounds |
| 08/03/2005 | CN1213045C Tyrosine kinase inhibitors |
| 08/03/2005 | CN1213028C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use |
| 08/03/2005 | CN1212831C Pharmaceutical preparations |
| 08/02/2005 | US6924415 Identified as a target for therapeutic intervention due to its role in molecular events that lead to or contribute to cardiac hypertrophy and/or dilated cardiomyopathy |
| 08/02/2005 | US6924413 Experimental animals for evaluation of therapeutic effects on corneal epithelial damages |
| 08/02/2005 | US6924376 Compounds, compositions and methods |
| 08/02/2005 | US6924357 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy |
| 08/02/2005 | US6924311 Measuring blood concentration of high density lipoproteins;medical diagnosis of cardiovasular disorders |
| 08/02/2005 | US6924303 Analgesic and anti-inflammatory compositions containing COX-2 inhibitors |
| 08/02/2005 | US6924280 Dipeptide derivatives |
| 08/02/2005 | US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
| 08/02/2005 | US6924141 Inducing the effects of promoted signal transduction with protein and lithium chloride or mimicking via administration of agent that inhibits either catenin phosphorylation or kinase |
| 08/02/2005 | US6924121 Sperm specific proteins |
| 08/02/2005 | US6924117 Human RRP sequences and methods of use |
| 08/02/2005 | US6924092 Testing prospective herbicides and parasiticides by incubating a substance with a monogalactodiacyl synthase or plastidal membrane products to select enzyme inhibitors; apicomplex parasites; antimalarial agents; coccidiosis;toxoplasmosis |
| 08/02/2005 | US6923981 Fast dissolving orally consumable films |
| 08/02/2005 | US6923967 comprises xanthophyll/astaxanthin esterified with fatty acid |
| 08/02/2005 | US6923965 comprises inhibitors of glycosaminoglycans; for wound healing and angiogenesis |
| 08/02/2005 | US6923959 Method of pre-inducing a state of immune tolerance before organ transplantation |
| 08/02/2005 | CA2326528C Cholesterol sulfate compositions for artificial skin tanning |
| 08/02/2005 | CA2325358C 7-¬(4'-trifluoromethyl-biphenyl-2-carbonyl)amino|-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein b |
| 08/02/2005 | CA2264094C Structured water for enhanced moisturization |
| 08/02/2005 | CA2170020C Retroviral protease inhibiting compounds |
| 08/02/2005 | CA2118121C Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 07/30/2005 | CA2495048A1 Hemostatic compositions and devices |
| 07/29/2005 | CA2493655A1 Transglutaminase has intrinsic kinase activity |
| 07/28/2005 | WO2005068624A1 Method of screening remedy for rheumatoid arthritis |
| 07/28/2005 | WO2005068504A1 Inflammatory cytokine inhibitor |
| 07/28/2005 | WO2005068468A2 Heterocyclic protein kinase inhibitors and uses thereof |
| 07/28/2005 | WO2005067974A1 Drug for regulating cancer metastasis to bone |
| 07/28/2005 | WO2005067973A2 Combination of crf antagonists and 5-ht 1b receptor antagonists |
| 07/28/2005 | WO2005067972A1 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 07/28/2005 | WO2005067970A1 Iron supplement and utilization of the same |
| 07/28/2005 | WO2005067969A2 Combinations of serotonin reuptake inhibitors and imidazoline-i2-agonists |
| 07/28/2005 | WO2005067947A1 Nonspecific anti-viral and anti-bacterial solution |
| 07/28/2005 | WO2005067946A1 Non-specific anti-viral and anti-bacterial (anti-microbial) solution |
| 07/28/2005 | WO2005067934A1 Use of substituted pyrimido pyrimido[5,4-d]pyrimidines in the treatment of diseases of the respiratory tract |
| 07/28/2005 | WO2005067921A1 Pharmaceutical compositions comprising higher primary aliphatic alcohols and hmg coa reductase inhibitor and process of preparation thereof |
| 07/28/2005 | WO2005067915A1 Synergistic neuroprotective combinations of flavanols, hydroxystilbenes, flavanones, flavones, flavonols, proanthocyanidins and anthocyanidins |
| 07/28/2005 | WO2005067909A1 Combination therapy with mecamylamine for the treatment of mood disorders |